Latest From Brainlab AG
The orthopedics giant will pay $27.50 per share for the Leesburg, Va., company, representing a 27% premium over K2M's average closing price over the last 90 days. The terms of the deal also call for K2M CEO to take over as president of Stryker's Spine business, displacing current president Bradley Paddock.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced January through February 2016.
The workshop will evaluate potential diagnostics, development strategies and datasets for traumatic brain injury. Multiple firms are working to bring different technologies for concussion detection to market.
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- MRI, NMR
Surgical Equipment & Devices
- Minimally or Less Invasive
- Diagnostic Imaging Equipment & Supplies
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Neurology, Nervous System
- BrainLAB AG
- Western Europe
- Parent & Subsidiaries
- Brainlab AG
- Senior Management
Stefan Vilsmeier, CEO
Joseph Doyle, CFO
- Contact Info
Phone: (49) 89 99 15680
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.